The molecular mechanisms underlying the ability of muscarinic agonists to enhance the metabolism of inositol phospholipids were studied using rat parotid gland slices prelabelled with tracer quantities of [3H] After stimulation with carbachol for 10min the levels of radioactive inositol 1,4-bisphosphate and inositol 1,4,5-trisphosphate greatly exceeded the starting level of radioactivity in phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate respectively. When carbachol treatment was followed by addition of sufficient atropine to block all the muscarinic receptors the radioactive inositol phosphates rapidly returned towards control levels. The carbachol-evoked changes in radioactive inositol phosphate and phospholipid levels were blocked in the presence of 2,4-dinitrophenol (an uncoupler of oxidative phosphorylation). The results suggest that muscarinic agonists stimulate a polyphosphoinositide-specific phospholipase C and that these lipids are continuously replenished from the labelled phosphatidylinositol pool.
1975; Berridge, 1981; Putney, 1981; Michell et al., 1981) . Acceptance of this idea has been limited by the lack of information concerning the precise molecular mechanism underlying agonist-stimulated phospholipid metabolism. For example, we can only determine the intracellular location of the response when we know the characteristics and in particular the substrate specificity of the enzyme(s) involved. Many Ca2+-mobilizing agonists can cause the disappearance of Ptdlns and therefore it was suggested that agonists could activate a PtdInsspecific phospholipase C (Michell, 1975; Michell et al., 1977; Jones et al., 1979; Irvine et al., 1982) . More recently it has become clear that the same group of agonists can provoke the disappearance of the polyphosphoinositides PtdIns4P and PtdIns(4,5)P2 (Durrell et al., 1968 Vol. 216 C. P. Downes and M. M. Wusteman Billah & Lapetina, 1983; Rhodes et al., 1983; Thomas et al., 1983) . We recently identified InsIP, Ins(1,4)P2 and Ins(1,4,5)P3 as products after stimulating Ca2+-mobilizing receptors in the blowfly salivary gland, rat parotid gland slices and rat brain slices . Thus receptor activation stimulates a phospholipidase C that degrades polyphosphoinositides. However, these previous experiments did not exclude the possibility of direct hydrolysis of PtdIns by the same enzyme(s). To resolve this question we have used rat parotid gland slices, prelabelled in vitro with [3Hlinositol, to provide a more detailed examination of the molecular mechanism underlying the enhanced metabolism of inositol phospholipids resulting from muscarinic receptor activation.
Methods
Rat parotid gland slices were prepared as described previously except that the collagenase treatment was omitted (Hanley et al., 1980) . Precise details of the incubation conditions for prelabelling parotid gland slices with [3H]inositol have been given in a previous publication . Briefly, the slices were incubated with [3Hlinositol (0.32pM; 12.5Ci/mmol) for 90min at 370C and then rinsed several times with KRB containing 1OmM unlabelled inositol. They were then incubated for a further 60min before rinsing again with the cold inositol/KRB. The prelabelled slices were allowed to settle under gravity and 40O1 portions were transferred to Beckman Biovials containing 200,u1 of unlabelled inositol/KRB. Drugs were added (lO,ul) from stock solutions in KRB. All incubations were stopped by adding 200,1 of ice-cold 15% (w/v) TCA.
Analysis of[3Hlinositolphosphates
TCA-treated samples were briefly centrifuged and 350,ul of the supernatant was transferred to separate tubes. TCA was removed by diethyl ether extraction and analysis of [3Hlinositol-labelled water-soluble compounds was by anion-exchange chromatography on Dowex-1 (formate) columns exactly as described previously . The following fractions were collected directly into 20ml counting vials: free inositol (2 x 6 ml of water); GroPIns (2 x 6 ml of 60mM-ammonium formate/5 mM-disodium tetraborate); InsIP (2 x 6 ml of 200mM-ammonium formate/100mM-formic acid); Ins(1,4)P2 (3 x 6ml of 400mM-ammonium formate/100mM-formic acid); Ins(1,4,5)P3 (4 x 3 ml of 1000mM-ammonium formate/100mM-formic acid). Radioactivity in the Ins(1,4,5)P3 fractions was determined by scintillation counting in the liquid phase using 80% (v/v) Aquasol (New England Nuclear). Radioactivity in all other fractions was determined by scintillation counting in the gel phase using 60% (v/v) Aquasol.
Analysis of [3H]inositolphospholipids
After removing samples of TCA-soluble material the remaining TCA was discarded. The precipitate was washed once with 1 ml of 5% TCA containing 1 mM-EDTA and once with water (Creba et al., 1983) . Chloroform/methanol/12M-HCl (40:80: 1; 940,u1) was then added and phospholipids were extracted for 10min at room temperature. Chloroform (310,u1) and 560,l of O.1M-HCI were then added and two phases were obtained by brief centrifugation. The lower phase was removed and dried under a stream of N2.
The dried lipid samples were dissolved in 0.5 ml of chloroform and the phospholipids were deacylated using a method based on that of Ellis et al. (1963) as described previously (Creba et al., 1983) . The resulting glycerophosphoryl esters were then separated by anion-exchange chromatography on the same columns that were used for separating inositol phosphates. The following fractions were collected directly into 20ml counting vials: GroPIns, the deacylation product of Ptdlns (2 x 6 ml of 60mM-ammonium formate/5 mM-disodium tetraborate); GroPIns4P, the deacylation product of PtdIns4P (2 x 6ml of 400mM-ammonium formate/lOOmMformic acid); GroPIns(4,5)P2, the deacylation product of PtdIns(4,5)P2 (4 x 3 ml of 1000mM-ammonium formate/100mM-formic acid). Radioactivity was determined by scintillation counting in the gel phase (GroPIns, GroPIns4P) . Acid chloroform/methanol extracts of the tissue pellets formed after treating the slices with TCA contained only three radioactive components that were identified after deacylation and separation of the resulting glycerophosphoryl esters on the same ion-exchange columns that were used for separating the acid-soluble compounds. These compounds were eluted in the positions expected for GroPIns, GroPIns4P and GroPIns(4,5)P2 as described previously for 32p labelled hepatocyte lipids (Creba et al., 1983) . Table 1 shows the distribution of radioactivity amongst the [3Hlinositol-containing components of parotid gland slices after the labelling and coldwashing cycle described in the Methods section. Most of the radioactivity was found in free inositol and PtdIns. The glands retained approx. 5% of the total label in the original incubations as free inositol despite extensive washing of the tissue slices in cold inositol/KRB. This retention of substantial levels of [3Hlinositol by the washed glands may indicate the existence of an active uptake process for inositol. This would be one explanation for the very high levels of myo-inositol in many tissues by comparison with plasma as suggested by Dawson & Freinkel (1961) . PtdIns4P and PtdIns(4,5)P2 accounted for only 3.2% and 2.9% respectively of the radioactivity in the TCA-insoluble fraction, presumably reflecting the much lower concentrations of these lipids in parotid glands compared with their precursor, PtdIns (assuming the three lipids are in isotopic equilibrium with one another, as discussed below). In control incubations only very low levels of radioactivity were found in the inositol phosphate and GroPIns fractions.
The labelled phospholipids and inositol phosphates clearly do not reach isotopic equilibrium with Vol. 216 the added [3H]inositol during the initial incubation period. However, it seems likely that the inositol phospholipids will reach isotopic equilibrium with one another extremely rapidly because the monoester phosphate groups of the polyphosphoinositides show metabolic turnover times of only a few minutes in a number of tissues (see Weiss et al. (1982) reported no change in 32P-labelled PtdIns4P. The mechanism that generates large accumulations of inositol phosphates with only modest falls in the steady-state levels of their radioactive parent lipids is discussed in the next section.
Examination of the data in Tables 1 and 2 suggests that the total increase in the TCA-soluble pool of 3H is twice the decrease in the TCA-insoluble pool. Comparison of the data from individual experiments demonstrated that this apparent discrepancy was not statistically significant (P > 0.05).
Comparison of carbachol-induced changes in labelled lipids and inositolphosphates more quantitative understanding of the changes induced by receptor activation, these events were examined in more detail. Fig. 1 Table 2 demonstrate that polyphosphoinositide resynthesis must occur for maximal generation of inositol phosphates. This could explain the apparent paradox that PtdIns disappearance evoked in platelets by thrombin (Holmsen et al., 1982) was extraordinarily sensitive to treatments that deplete cellular ATP levels. Our results suggest that PtdIns disappears as it is used to resynthesize polyphosphoinositides via two ATPdependent reactions catalysed by PtdIns kinase and PtdIns4P kinase respectively. We therefore examined the effects of an uncoupler of oxidative phosphorylation, DNP, on carbachol-stimulated inositol phospholipid metabolism in the parotidgland slice preparation.
As shown in Table 3 , incubating parotid-gland slices with DNP (0.5 mM) for 20min caused a large (approx. 50%) decrease in labelled polyphosphoinositides levels with no change in the level of
[3H]PtdIns. The most likely explanation for this result is that DNP treatment leads to a rapid decline in cellular ATP and a correspondingly rapid loss of polyphosphoinositides. If this interpretation is correct then the results demonstrate the rapid rate of metabolic turnover of the monoester phosphates of the [3Hlinositol-labelled pool of polyphosphoinositides as suggested by their rapid rate of labelling with
[32p]p1 (Weiss et al., 1982 [3HIPtdIns(4,5)P2, perhaps because the initial loss of these lipids after DNP treatment (presumably through phosphomonoesterase attack) removes most of the substrate available for the receptorstimulated phospholipase C. These effects of DNP were not due to irreversible membrane damage bacause the levels of radioactivity in the polyphosphoinositides and the response to carbachol returned to normal when DNP was removed by washing pretreated slices several times with KRB. Discussion Previous work has demonstrated that Ca2+_ mobilizing agonists acting on blowfly salivary glands, rat brain slices and rat parotid-gland slices can stimulate hydrolysis of polyphosphoinositides by phospholipase C activity. However, the precise substrate specificity of the enzyme(s) involved remains uncertain. Three possibilities seem worth considering. The enzyme(s) could attack PtdIns, PtdIns4P and Ptdlns(4,5)P2, leading to direct formation of their respective inositol phosphate headgroups; PtdIns4P and PtdIns4P(4,5)P2 could both be attacked directly with InsIP being formed by Ins(1,4)P2 hydrolysis and not directly from Ptdlns; Ptdlns(4,5)P2 could be attacked directly with both Ins(l,4)P2 and InsIP being formed via hydrolysis of Ins(1,4,5)P3.
We can now reject the idea of direct formation of InsIP from PtdIns on several grounds. In previous work we failed to detect the formation of inositol 1: 2-cyclic phosphate as a product after stimulation of different tissues with Ca2+-mobilizing agonists, suggesting that the PtdInsspecific phospholipase C, which generates a mixture of Ins IP and inositol 1: 2-cyclic phosphate as products (see Irvine et al., 1982) , is not involved. There was a detectable time-lag for the formation of Ins IP, but not for Ins(1,4)P2 or Ins(1,4,5)P3 (Fig. 1) . Assuming that InsIP is a product of Ins(1,4)P2 hydrolysis by the phosphatase activity demonstrated in Fig. 2 Holmsen et al. (1982) . As mentioned previously ATP would be required to fuel PtdIns kinase and PtdIns4P kinase.
Carbachol is known to provoke extensive disappearance of Ptdlns in rat parotid glands (up to 30% in 5 min; Jones & Micheil, 1974 Weiss et al. (1982) to the reasonable conclusion that the enzyme involved preferred to attack PtdIns(4, 5) . Furthermore, Li+ specifically inhibits InsiP hydrolysis in a variety of tissues (Hallcher & Sherman, 1980; Sherman et al., 1981; Berridge et al., 1982) , suggesting that there is a distinct Ins iP phosphomonoesterase in many tissues. Li+ is used to treat the symptoms of manic depression and it has been argued that Li+ may exert its therapeutic effect by limiting the availability of free inositol (Sherman et al., 1981; Berridge et al., 1982) . If (1975, 1979) to suggest that Ptdlns breakdown might be an essential reaction that couples receptor occupation to Ca2+-mobilization. The present results provide compelling evidence to support our previous suggestion Michell et al., 1981; Creba et al., 1983 ) that polyphosphoinositide breakdown should replace Ptdlns breakdown in this role. Ptdlns probably disappears, as it is used to replenish the polyphosphoinositide pools. How might phospholipase C attack upon polyphosphoinositides lead to an increase in cytosol Ca2+ concentration? One possibility is that conversion of Ptdlns(4,5)P2 (the most polar, acidic phospholipid known) into diacylglycerol (a neutral, hydrophilic lipid) might act as a trigger to release Ca2+ from membrane-bound stores. Alternatively the water-soluble products of phospholipase C activity, Ins(1,4,5)P3 and/or Ins(1,4)P2, could act as second messengers and themselves catalyse Ca2+ release as suggested recently by Berridge (1983) . In addition to this putative role for polyphosphoinositide breakdown in cellular Ca2+-mobilization, diacylglycerol formed by phospholipase C activity can act as a trigger for activating protein kinase C (Takai et al., 1981; Kaibuchi et al., 1982) . The rate of formation of these potentially important products (inositol phosphates and diacylglycerol) depends upon the activity of the receptor-stimulated phospholipase C and upon the rate at which the polyphosphoinositides can be resynthesized by PtdIns kinase and PtdIns4P kinase. These synthesizing enzymes can maintain substantial-levels of polyphosphoinositides even when the phospholipase C is activated by high doses of carbachol.
In conclusion, it now seems certain that muscarinic agonists act on the parotid gland by stimulating a polyphosphoinositide-specific phospholipase C. Our previous work suggests the same mechanism may operate for the other Ca2+-mobilizing receptors of the parotid (a, and Substance P) and for such receptors in the brain and the blowfly salivary gland . The polyphosphoinositide pools labelled by [3Hlinositol can be broken down and resynthesized several times within a 10min period of stimulation and yet substantial levels of the lipids are maintained in the membrane. This may imply that there is also a high degree of control (perhaps secondary to control of the phospholipase C by activated receptors) at the level of PtdIns and PtdIns4P kinases.
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